MoneyTree: Nation's Biggest Bioclusters Record Declines in VC Spending in Q2
July 24, 2009
MoneyTree: Nation's Biggest Bioclusters Record Declines in VC Spending in Q2
The San Francisco Bay Area and Boston/Cambridge, Mass., fared better in biotech activity than almost the entire next tier of large life-sci clusters, but worse than several up-and-coming regions, which saw either smaller year-to-year losses, or actual gains.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- VC Funding in Life Sciences Plummets in Q2, Report Finds
August 16, 2012 / GenomeWeb Daily News - MoneyTree Reports Overall Drop in Q1 Biotech VC Funding, But Smaller Declines in Boston and Bay Area Clusters
April 24, 2009 / - BioMed Realty Trust Paint Bright Picture Despite Recent Dip in San Fran Life-Sci Leasing
March 9, 2009 / - MoneyTree Report Shows VC Investment in Biotech Startups Slips 20 Percent in Q4
January 26, 2009 / - Clovis Pulls Plug on Personalized Cancer Drug after Trial Shows No Benefit for Drug or Marker
November 14, 2012 / Pharmacogenomics Reporter